BE2016C041I2 - - Google Patents

Download PDF

Info

Publication number
BE2016C041I2
BE2016C041I2 BE2016C041C BE2016C041C BE2016C041I2 BE 2016C041 I2 BE2016C041 I2 BE 2016C041I2 BE 2016C041 C BE2016C041 C BE 2016C041C BE 2016C041 C BE2016C041 C BE 2016C041C BE 2016C041 I2 BE2016C041 I2 BE 2016C041I2
Authority
BE
Belgium
Prior art keywords
hydroxypyrone
iron
reacting
carboxylic acid
aqueous solution
Prior art date
Application number
BE2016C041C
Other languages
Dutch (nl)
Original Assignee
Shield Tx Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shield Tx Uk Ltd filed Critical Shield Tx Uk Ltd
Publication of BE2016C041I2 publication Critical patent/BE2016C041I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A method of forming an iron hydroxypyrone compound comprising reacting an iron salt of a carboxylic acid and a hydroxypyrone in an aqueous solution at a pH greater than 7.
BE2016C041C 2002-05-18 2016-08-17 BE2016C041I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds
PCT/GB2003/001956 WO2003097627A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds

Publications (1)

Publication Number Publication Date
BE2016C041I2 true BE2016C041I2 (en) 2022-08-09

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2016C041C BE2016C041I2 (en) 2002-05-18 2016-08-17

Country Status (11)

Country Link
US (1) US7459569B2 (en)
EP (1) EP1506183B1 (en)
AT (1) ATE352547T1 (en)
AU (1) AU2003233881A1 (en)
BE (1) BE2016C041I2 (en)
CA (1) CA2483067C (en)
DE (1) DE60311456T2 (en)
ES (1) ES2283771T3 (en)
FR (1) FR16C0033I2 (en)
GB (1) GB0211500D0 (en)
WO (1) WO2003097627A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
MX2009008281A (en) 2007-02-06 2009-08-25 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation.
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
JP7033546B2 (en) * 2016-03-31 2022-03-10 シールド ティーエックス （ユーケー） リミテッド Methods for Producing Maltol Ferric Compositions from Elemental Iron
AU2017242901B2 (en) * 2016-03-31 2020-11-19 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
JP7033544B2 (en) * 2016-03-31 2022-03-10 シールド ティーエックス （ユーケー） リミテッド A method for producing a maltol ferric composition from ferric hydroxide
EP3435999B1 (en) 2016-03-31 2021-04-28 Shield TX (UK) Limited Ferric maltol compositions for use in the treatment or prevention of cancer and tumours
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (en) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 Maltoferric crystal form II and preparation method thereof
CN115177625A (en) * 2022-06-28 2022-10-14 金陵药业股份有限公司 Carboxyl ferric maltose pharmaceutical composition and preparation method thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
DE1518098A1 (en) 1963-09-19 1969-04-10 Pfizer & Co C Process for the preparation of pyromeconic acid derivatives
SE322866B (en) 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
CY1501A (en) 1982-03-24 1990-08-03 Nat Res Dev Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or-4-one derivatives
GR78491B (en) 1982-03-24 1984-09-27 Nat Res Dev
GB2128998B (en) 1982-10-22 1986-07-16 Nat Res Dev Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone
GB8308054D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (en) 1989-08-07 1991-03-22 Kansai Paint Co Ltd Iron-enriched food
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
ES2230564T3 (en) * 1995-06-10 2005-05-01 Vitra Pharmaceuticals Ltd. FERRIC COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE OF THESE AND ITS USED.
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
ATE352547T1 (en) 2007-02-15
EP1506183A1 (en) 2005-02-16
AU2003233881A1 (en) 2003-12-02
WO2003097627A1 (en) 2003-11-27
DE60311456D1 (en) 2007-03-15
DE60311456T2 (en) 2007-11-15
FR16C0033I1 (en) 2016-09-23
GB0211500D0 (en) 2002-06-26
ES2283771T3 (en) 2007-11-01
US7459569B2 (en) 2008-12-02
FR16C0033I2 (en) 2018-01-19
CA2483067C (en) 2011-04-26
CA2483067A1 (en) 2003-11-27
US20050250754A1 (en) 2005-11-10
EP1506183B1 (en) 2007-01-24

Similar Documents

Publication Publication Date Title
BE2016C041I2 (en)
EP2272825A3 (en) N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation
MXPA03009565A (en) Carboxylic acid derivative and salt thereof.
AU2001281028A1 (en) Dilute acid/metal salt hydrolysis of lignocellulosics
ZA200308319B (en) Method for producing an aqueous acrylamide solution with a biocatalyst.
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
MXPA03000510A (en) Stable salts of o-acetylsalicyclic with basic amino acids.
AU1595702A (en) Method of producing carboxylic acid salts
WO2003088956A8 (en) Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
EP1767521A4 (en) L-ornithine-citric acid salt crystal
RS50685B (en) Concentrated aqueous solution of ambroxol
PL365213A1 (en) Enteric ketoacid salts and amino acids
IL157495A0 (en) Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs
WO2004095921A3 (en) Sporicidal composition
WO2002024001A3 (en) Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
IN2003CH01298A (en) Method for producing D-pantothenic acid and/or salt thereof as additive for animal feesdstuffs
IL157496A0 (en) Method for producing d-pantothenic acid and/or salts thereof as additive to animal feed
IL157402A0 (en) Method for producing d-pantothenic acid and/or salts therefor as an additive for animal feed
AU2002250978A1 (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
BG102347A (en) New carboxylic acid derivatives, method for their preparation and application
AU2001249606A1 (en) Method of cyanide salt production
MY134147A (en) Method for stoping hysteresis
UA30209A (en) A method for use of tetradimethyl sulfoxide hexamethylene tetraminbisdichloride of cobalt (II) to increase agricultural crop-production power
GB0227732D0 (en) Dissolution method of co precipitate with acid
BG105780A (en) Method for producing derivatives of biphenyl-2-carboxylic acid